Remote Monitoring

Remote patient monitoring (RPM) uses technologies to gather and track patient data outside standard healthcare settings. Cardiology was one of the first medical specialties to incorporate RPM into standard practice. Using remote monitoring of either wearable devices or an implanted electrophysiology (EP) device, patients can me monitored outside of office, clinic or hospital settings. The technology also offers the ability to catch serious health problems prior to a major clinical event. Some studies of these technologies have shown a 50% drop in mortality from arrhythmias and congestive heart failure compared to those receiving standard, in-person follow-ups. Remote patient monitoring use was taken to a new all-time higher during the COVID-19 pandemic, since two allowed patients, including COVID patients, to be monitored at home and helped limit patient-clinician contact while providing high quality tele-medicine care. It is widely expected that RPM will become a staple of cardiac care following the pandemic. 

The Medtronic Linq II implantable cardiac monitor.

The Medtronic Linq II implantable cardiac monitor.

News | Atrial Fibrillation | September 08, 2021
September 8, 2021 — Continuous heart rhythm monitoring – with anticoagulation if atrial fibrillation is detected – does...
The Medtronic Reveal Linq implantable cardiac monitor (ICM) was used in the SMART-MI study. It is inserted under the skin in a simple, fast outpatient procedure. The device is smaller than a AAA battery.

The Medtronic Reveal Linq implantable cardiac monitor (ICM) was used in the SMART-MI study. It is inserted under the skin in a simple, fast outpatient procedure. The device is smaller than a AAA battery.

News | Implantable Cardiac Monitor (ICM) | September 07, 2021
September 7, 2021 — Remote monitoring of implantable cardiac monitors (ICMs) is highly effective for early detection of...
A team at the University of South Australia designed a computer vision system that can automatically detect a baby’s face in a hospital bed and remotely monitor its vital signs from a digital camera with the same accuracy as a traditional ECG machine.

A team at the University of South Australia designed a computer vision system that can automatically detect a baby’s face in a hospital bed and remotely monitor its vital signs from a digital camera with the same accuracy as a traditional ECG machine.

News | ECG | September 01, 2021
September 1, 2021 — University of South Australia researchers have designed a computer vision system that can...
BioMonitor IIIm is a miniature electrocardiogram (ECG) device which records, stores and transmits clinical data that is integral in the diagnosis and long-term monitoring of cardiac patients, with maximum precision and for an extended period of time.

BioMonitor IIIm is a miniature electrocardiogram (ECG) device which records, stores and transmits clinical data that is integral in the diagnosis and long-term monitoring of cardiac patients, with maximum precision and for an extended period of time.

News | Implantable Cardiac Monitor (ICM) | August 09, 2021
August 9, 2021 - In association with Heart Rhythm 2021, Biotronik today announced that the latest implantable cardiac...
The devices compared in the study were the Bardy Carnation Ambulatory Monitor long-term continuous ECG system (left) and the BioGuardian MCT cardiac event monitor (right).  #HRS21 #HRS2021 #HeartRhythm21

The devices compared in the study were the Bardy Carnation Ambulatory Monitor long-term continuous ECG system (left) and the BioGuardian MCT cardiac event monitor (right). 

News | EP Lab | July 29, 2021
July 29, 2021 – Results from a new clinical trial found human-oversight dependent continuous electrocardiography (ECG)...
The BardyDx Carnation Ambulatory Monitor (CAM) is a P-wave centric wearable ambulatory cardiac patch monitoring and arrhythmia detection device. 

The BardyDx Carnation Ambulatory Monitor (CAM) is a P-wave centric wearable ambulatory cardiac patch monitoring and arrhythmia detection device. 

News | Cardiac Diagnostics | July 29, 2021
July 29, 2021 — A recent clinical study from Overlake Medical Center utilizing the Bardy Diagnostics Carnation...
The AcQMap 3D Imaging and Mapping System, left, and the AliveCor KardiaMobile device and app for personal ECG monitoring using a smartphone, right. The companies plan to use remote monitoring to see if it helps improve care for ablation patients.

The AcQMap 3D Imaging and Mapping System, left, and the AliveCor KardiaMobile device and app for personal ECG monitoring using a smartphone, right. The companies plan to use remote monitoring to see if it helps improve care for ablation patients.

News | EP Lab | July 27, 2021
July 27, 2021 — AliveCor Inc., which offers FDA-cleared, smart-phone enabled personal electrocardiogram (ECG)...
In the past decade there has been a proliferation of clinical-grade wearable monitors and implantable devices such as pacemakers, ICDs, implantable cardiac monitors, and new pacemaker-like devices that can control hypertension. In the near future, these devices will be tied into a body-wide internet of things for specific patients that can transmit patient data to clinicians wirelessly to enable an integrated, more robust form of telecardiology and telemedicine.

In the past decade there has been a proliferation of clinical-grade wearable monitors and implantable devices such as pacemakers, ICDs, implantable cardiac monitors, and new pacemaker-like devices that can control hypertension. In the near future, these devices will be tied into a body-wide internet of things for specific patients that can transmit patient data to clinicians wirelessly to enable an integrated, more robust form of telecardiology and telemedicine.

Feature | Telecardiology | July 23, 2021 | Victor Wollesen
Cardiovascular diseases are among the leading causes of death for people over 65 years old in North America and Europe...
Medtronic announced clinical trial results from the STROKE AF trial demonstrating the superiority of the Reveal Linq Insertable Cardiac Monitor (ICM) to detect abnormal heartbeats, otherwise known as atrial fibrillation (AF), in both large and small vessel stroke patients compared to standard of care.
News | Implantable Cardiac Monitor (ICM) | July 14, 2021
June 13, 2021 — Medtronic announced clinical trial results from the STROKE AF trial demonstrating the superiority of...
The FDA has cleared Angel Medical Systems' second-generation AngelMed Guardian device. The implantable cardiac device detects and warns patients if they are having an acute coronary syndrome (ACS) event, including silent heart attacks. The new, second-generation device is enhanced with ease-of-use adaptations and an updated, long life battery that could potentially double the life of the implanted device

The FDA has cleared Angel Medical Systems' second-generation AngelMed Guardian device. The implantable cardiac device detects and warns patients if they are having an acute coronary syndrome (ACS) event, including silent heart attacks. The new, second-generation device is enhanced with ease-of-use adaptations and an updated, long life battery that could potentially double the life of the implanted device

News | Cardiac Diagnostics | July 01, 2021
July 1, 2021 — The U.S. Food and Drug Administration (FDA) has cleared the Angel Medical Systems Inc. second-generation...
Telecradiology remote monitroing programs grew rapidly during the COVID-19 pandemic. An example of a remote cardiac monitor that saw increased use is InfoBionic's MoMe Kardia device. It offers mobile cardiac telemetry with near real-time, on-demand full disclosure of ECG data 24/7. Using a wearable monitor, MoMe continuously records telemetry data, uploading it to a cloud-based platform that clinicians may access at anytime.

Telecradiology remote monitroing programs grew rapidly during the COVID-19 pandemic. An example of a remote cardiac monitor that saw increased use is InfoBionic's MoMe Kardia device. It offers mobile cardiac telemetry with near real-time, on-demand full disclosure of ECG data 24/7. Using a wearable monitor, MoMe continuously records telemetry data, uploading it to a cloud-based platform that clinicians may access at anytime.

News | Remote Monitoring | June 22, 2021
June 22, 2021 — It is no secret that the use of telehealth technologies rose dramatically with the onset of the COVID-...
Implicity provides a remote cardiac monitoring and research platform used by Independent Diagnostic Testing Facilities and medical centers to deliver high-quality care for patients with connected cardiac devices. On this platform, Implicity aggregates, normalizes and standardizes data from any implantable cardiac device across all manufacturers.

Implicity provides a remote cardiac monitoring and research platform used by Independent Diagnostic Testing Facilities and medical centers to deliver high-quality care for patients with connected cardiac devices. On this platform, Implicity aggregates, normalizes and standardizes data from any implantable cardiac device across all manufacturers.

News | EP Lab | June 02, 2021
June 2, 2021 — Implicity, a leader in remote patient monitoring software and cardiac data management solutions,...
The Consumer Technology Association (CTA) is collaborating with the American College of Cardiology (ACC) and several vendors on best practices for device and app and wearable device makers to provide deeper understanding of products that manage cardiovascular health. #wearables

The Consumer Technology Association (CTA) is collaborating with the American College of Cardiology (ACC) and several vendors on best practices for device and app and wearable device makers to provide deeper understanding of products that manage cardiovascular health. 

News | Wearables | May 10, 2021
May 10, 2021 – Today, the Consumer Technology Association (CTA) announced it is collaborating with the American College...
PA pressure-guided heart failure management is fast becoming the standard of care in NYHA Class III patients. The Cordella Pulmonary Artery Pressure Sensor enables clinicians to remotely monitor and proactively adjust therapy and medications remotely without the need for office visits.

PA pressure-guided heart failure management is fast becoming the standard of care in NYHA Class III patients. The Cordella Pulmonary Artery Pressure Sensor enables clinicians to remotely monitor and proactively adjust therapy and medications remotely without the need for office visits.

News | Heart Failure | March 24, 2021
March 24, 2021 — Endotronix Inc., a digital health and medical technology company working on advancements in treating...